Skip to content
MarketNewsAPI
Live news Screener Coverage Pricing Docs REST API WebSocket API MCP server Company Use cases Blog Changelog Status Compare Contact
Log in Get API key Dashboard
TECK$59.05+0.15(+0.25%)Teck Provides Update on Highland Valley Copper Operations[3:18:56 PM ET]AXON$422.00+7.40(+1.78%)Axon Announces Body 5: Next-Generation Camera Built for the AI Era Axon (Nasdaq: AXON), the global leader in public safety technology, today announced Axon Body 5, its newest body-worn camera designed to bring more...[1:00:00 PM ET]PFE$30.02-0.40(-1.31%)Pfizer's 25-Valent Pediatric Pneumococcal Conjugate Vaccine Candidate Shows Robust Phase 2 Data at IDWeek 2026[11:18:00 AM ET]BIVI$1.24-0.04(-3.13%)From Private Credit to Fusion Power: New to The Street Show #777 Premieres Tonight on Bloomberg Television[10:30:00 AM ET]AMGN$439.26-8.02(-1.79%)IMDELLTRA® IN COMBINATION WITH IMFINZI® REDUCED RISK OF DEATH BY AN UNPRECEDENTED 58% IN FIRST-LINE EXTENSIVE STAGE SMALL CELL LUNG CANCER Amgen (NASDAQ:AMGN) today announced landmark interim Phase 3 results showing that IMDELLTRA® (tarlatamab-dlle) in combination with AstraZeneca's...[10:30:00 AM ET]JNJ$263.81-3.80(-1.42%)Johnson & Johnson announces ERLEADA® (apalutamide) treatment before and after surgery reduces risk of recurrence or death by 62% versus surgery alone in high-risk prostate cancer Johnson & Johnson (NYSE: JNJ) today announced new results from the Phase 3 PROTEUS substudy that directly compared the investigational use of...[8:54:00 AM ET]PBLS$24.79-2.13(-7.91%)Parabilis Medicines Presents Updated Phase 1/2 Data for Zolucatetide Demonstrating Compelling Efficacy and Favorable Safety and Tolerability Profile in Patients with Desmoid Tumors[8:45:00 AM ET]SMTC$131.80+6.68(+5.34%)Semtech Brings 5G Network Slicing, FIPS 140-3 to IACP 2026[8:00:00 AM ET]GMAB$43.85+3.85(+9.63%)Genmab and Incyte Announce Clinical Trial Collaboration in Metastatic Colorectal Cancer[7:00:00 AM ET]INCY$115.00-1.93(-1.65%)Incyte and Genmab Announce Clinical Trial Collaboration in Metastatic Colorectal Cancer[7:00:00 AM ET]NBTX$29.36+0.17(+0.58%)NANOBIOTIX Announces Final Data from Phase 1 Study Evaluating JNJ-1900 (NBTXR3) With Immune Checkpoint Inhibitors as a 2L+ Therapy in Anti-PD-1-Resistant Primary Cutaneous Melanoma[7:00:00 AM ET]

OKLO · NYSE

Oklo Inc.

$26.32 -0.61 (-2.24%)

Company overview

Oklo Inc. designs and develops fission power plants to provide reliable, commercial-scale energy to customers in the United States. The company also provides used nuclear fuel recycling services. Oklo was founded in 2013 and is based in Santa Clara, California.

Sector
Utilities
Industry
Regulated Electric
Exchange
NYSE
Market cap
$4.9B
Employees
120
Headquarters
Santa Clara, CA
Website
oklo.com
CEO
Jacob Dewitte
Listed
July 8, 2021
P/E
-31.33
Dividend yield
0.00%

Company financials

Revenue
$0.00
Gross profit
-$163,000
Operating income
-$173M
EBITDA
-$172M
Net income
-$129M
EPS
-$0.84
Total assets
$2.7B
Total debt
$2.6M
Earnings yield
-3.19%

Revenue segmentation

By product

No annual segmentation.

By region

No geographic segmentation.

Price chart

23.8538.8253.7968.7583.72
OKLO 1D NYSE O26.68H26.90L26.07C26.35-0.66 (-2.44%)Vol6.12M

News

15-min delaySigned-out view is delayed 15 minutes. Log in on Pro for the live news desk.

Start 7-day free trial See live plans
Source
Date
Type
Ticker Type Headline Source Published
OKLO Stock news Oklo Is Down 61% This Year Despite a Real Technical Milestone. Here's the Disconnect Between the Stock and the Science. The Motley Fool
OKLO Press release Oklo Announces Date for Third Quarter 2026 Financial Results and Business Update Call Business Wire
OKLO Stock news Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought Fool - Investing News
OKLO Stock news Oklo Could Have a Huge Opportunity as Demand for Advanced Nuclear Energy Grows 24/7 Wall Street
OKLO Stock news Top Nuclear Stocks To Research – October 16th Defense World
OKLO Stock news Contrasting Spruce Power (NYSE:SPRU) & Oklo (NYSE:OKLO) Defense World
OKLO Stock news 5 Growth Stocks With Home Run Potential Fool - Investing News
OKLO Stock news NuScale Power Falls 7% as 10-Year Treasury Yield Climbs to 5.26%; Energy Fuels Drops 9%, Oklo Slides 5% 24/7 Wall Street
OKLO Stock news A Year Ago We Said the SMR Rally Was Just Heating Up. Oklo and NuScale Both Fell Sharply. 24/7 Wall Street
OKLO Stock news Oklo Launched Another $1 Billion Stock Sale. Here's How Much Dilution Shareholders Have Absorbed Since It Went Public. The Motley Fool
OKLO Stock news Google Signed a Deal for Existing Reactors. So Why Did Oklo and NuScale Jump on the Constellation Energy News? The Motley Fool
OKLO Stock news Oklo Stock Hits a New 52-Week Low: Time to Buy? The Motley Fool
OKLO Stock news Is Oklo Stock Your Ticket to Becoming a Millionaire? The Motley Fool
OKLO Stock news OKLO Builds on Groves Progress to Expand Isotope Business Zacks Investment Research
OKLO Press release Oklo to Advance Groves 2 Forge as Part of U.S. Department of Energy's Nuclear Energy Launch Pad Selection Business Wire
OKLO Stock news NuScale Power Sinks 7% as Nuclear Names Give Back a Month of Ground; Oklo Falls 6%, Centrus Energy Drops 4% 24/7 Wall Street
OKLO Stock news Nuclear Stocks To Follow Now – October 10th Defense World
OKLO Stock news Here's Where These 4 Nuclear Reactor Stocks Could Be in 5 Years The Motley Fool
OKLO Stock news Is Oklo the Next Trillion-Dollar Stock? The Motley Fool
OKLO Stock news NuScale Power Is Now Down 49% This Year: Is SMR Stock Dead Money or Due for a Bounce? 24/7 Wall Street
See more
FAQ

Questions about Oklo Inc.

What does Oklo Inc. do?
Oklo Inc. designs and develops fission power plants to provide reliable, commercial-scale energy to customers in the United States. The company also provides used nuclear fuel recycling services. Oklo was founded in 2013 and is based in Santa Clara, California.
What is OKLO's market cap?
Oklo Inc. (OKLO) is a listed stock with a live quote. The latest market cap on this page is $4.9B.
Where is Oklo Inc. headquartered?
Oklo Inc. is headquartered in Santa Clara, CA.
How do I get OKLO news from the API?
Call GET /v1/news?tickers=OKLO. Add type=news, type=press_release, or type=legal to take one feed. Pro keys search the full archive in real time. Free keys are delayed 15 minutes and return the last year. Signed-out visitors and Free accounts see that same year on this page. Pro sees the full archive.
How far back does OKLO news go?
Signed-out visitors and Free accounts see the last year of stock news, press releases, and legal notices for OKLO, 15 minutes behind, and each headline links to the publisher. Pro, including the 7-day trial, sees the full archive as headlines are ingested. A Free API key returns the last year. Pro keys search the full archive.
Is the OKLO price on this page from the API?
The price and daily change update during the US session for every visitor. That quote is context on this page. It is not part of the news API. The chart is one candle per session from the start of 2020. 1W, 1M, and 1Y group those sessions.

Real-time stock news for $15 a month.

Start a 7-day Pro trial. A card is required. REST, WebSocket, and MCP are included, with 2,000 REST requests a day. Paid Pro removes the daily cap. If you don't subscribe, the account stays on Free.

Start 7-day free trial Read the docs